A Novel Approach for Reducing Ischemic Mitral Regurgitation by Injection of a Polymer to Reverse Remodel and Reposition Displaced Papillary Muscles
Author(s) -
Judy Hung,
Jorge Solı́s,
Jorge Guerrero,
Gavin Braithwaite,
Orhun K. Muratoglu,
Miguel Chaput,
Leticia FernándezFriera,
Mark D. Handschumacher,
Van J. Wedeen,
Stuart L. Houser,
Gus J. Vlahakes,
Robert A. Levine
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.756502
Subject(s) - medicine , vena contracta , papillary muscle , cardiology , ejection fraction , mitral regurgitation , ligation , heart failure
Ischemic mitral regurgitation (MR) relates to displacement of the papillary muscles from ischemic ventricular distortion. We tested the hypothesis that repositioning of the papillary muscles can be achieved by injection of polyvinyl-alcohol (PVA) polymer, a biologically inert biomaterial that has been specially formulated to produce an encapsulated, stable, resilient gel once injected into the myocardium. The purpose is to materially support the infarcted myocardium while at the same time repositioning the papillary muscles that become apically tethered in MR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom